Please assess the completion status of the following clinical trial:

Trial Title: PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males/females with CDAD~* Females must use adequate contraception~* Signed informed consent~Exclusion Criteria:~* Life-threatening CDAD~* Toxic megacolon~* Pregnant~* Concurrent use of diarrheal agents~* Participation in other trials

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Vancomycin
- 2 (Type: EXPERIMENTAL): PAR-101/OPT-80

Based on this trial design, predict the completion outcome and termination type (if applicable).